SLC2A1 Gene Paroxysmal exercise-induced dyskinesia with epilepsy and/or hemolytic anemia NGS Genetic Test
Short Name: SLC2A1 NGS Genetic Test
Also known as: PED with epilepsy and/or hemolytic anemia, SLC2A1-related paroxysmal dyskinesia, GLUT1 deficiency-related paroxysmal dyskinesia
SLC2A1 Gene Paroxysmal exercise-induced dyskinesia with epilepsy and/or hemolytic anemia NGS Genetic Test test available at DNA Labs India for ₹20,000. Uses Next Generation Sequencing (NGS) on Blood or Extracted DNA or One drop Blood on FTA Card samples. Results in Reports are generally available within 3 to 4 weeks after the sample reaches the laboratory.. Free home collection in 300+ cities across India.
🩺 Medically Reviewed By
Dr SULOCHANA HEMCHANDRA HOLLA
Consultant Medical Geneticist · Reg: 8532
Last reviewed: September 7, 2026
Overview
To detect pathogenic or likely pathogenic variants in the SLC2A1 gene using next generation sequencing, confirm the clinical diagnosis of SLC2A1-related paroxysmal exercise-induced dyskinesia with epilepsy and/or hemolytic anemia, and enable genetic counselling for at-risk family members.
- Test Code
- 4450
- Price
- ₹20,000
- Sample Type
- Blood or Extracted DNA or One drop Blood on FTA Card
- Result Time
- Reports are generally available within 3 to 4 weeks after the sample reaches the laboratory.
- Fasting Required
- No
- Method
- Next Generation Sequencing (NGS)
Sample Collection
No fasting or special preparation is required. A genetic counselling session may be arranged before the test to review family history, explain the genetic basis, and obtain informed consent.
Method: Venipuncture / FTA card blood spot
Laboratory Analysis
For a whole blood sample, a phlebotomist will collect blood from a vein using a sterile needle. If an FTA card is used, a few drops of blood will be applied on the card and allowed to air dry before sealing.
Report Delivery
After sample collection, the patient can return to normal daily activities. The sample will be transported to the laboratory for NGS analysis.
Timeline: Reports are generally available within 3 to 4 weeks after the sample reaches the laboratory.
Patient Instructions
About This Test
Who Should Get This Test
To detect pathogenic or likely pathogenic variants in the SLC2A1 gene using next generation sequencing, confirm the clinical diagnosis of SLC2A1-related paroxysmal exercise-induced dyskinesia with epilepsy and/or hemolytic anemia, and enable genetic counselling for at-risk family members.
How to Prepare
- Carry a valid doctor's prescription and previous medical records
- Accurately fill the test requisition form with clinical history and family history
- Ensure the sample is collected in an EDTA vacutainer or on an FTA card as instructed
- Label the sample tube or FTA card with patient name, date of birth, collection date and unique ID
- Inform the laboratory if the patient has had a recent blood transfusion
Doctor's Notes
Reviewed by Dr SULOCHANA HEMCHANDRA HOLLA — MBBS, MD (Medical Genetics) · Reg. No. 8532
"When a familial SLC2A1 variant is identified, genetic testing of at-risk relatives can clarify recurrence risks and support reproductive planning. I recommend coordinating this with a clinical geneticist for comprehensive counselling."
Last medically reviewed: September 7, 2026
Test Parameters & Specifications
Sample Stability
- Unlabelled or mislabelled sample
- Insufficient sample quantity or empty tube
- Haemolysed or clotted blood sample
- FTA card wet, contaminated, or not air-dried properly
- Sample received in unsuitable transport media
Understanding Your Results
Pathogenic or likely pathogenic variant detected in SLC2A1
Provides molecular confirmation of the clinical diagnosis in most cases and supports referral for targeted management and family segregation testing.
Action: Discuss with clinical genetics and neurology; arrange genetic counselling; consider testing at-risk relatives.
Variant of uncertain significance (VUS) detected
Inconclusive; the variant has not yet been classified as pathogenic or benign.
Action: Further family studies, segregation analysis and/or functional studies may be recommended.
No pathogenic variant detected in SLC2A1
Reduces but does not exclude SLC2A1-related disorder; other genetic or non-genetic causes should be considered.
Action: Consider a multi-gene panel or clinical re-evaluation; genetic counselling is recommended.
If the result shows a pathogenic or likely pathogenic SLC2A1 variant, consult a clinical geneticist or neurologist for further management and family counselling. If a VUS is reported, a genetic counsellor can help determine next steps. Persistent clinical symptoms despite a negative result also warrant re-evaluation.
Limitations
- ⚠NGS may not detect all types of mutations, including large structural variants, deep intronic variants or epigenetic changes
- ⚠A variant of uncertain significance (VUS) may be reported and is not a definitive positive or negative result
- ⚠A negative result does not exclude a diagnosis of SLC2A1-related disorder
- ⚠Results must be correlated with clinical findings and interpreted by a qualified clinician
Risks & Considerations
- ●Minor discomfort or bruising at the venipuncture site
- ●Mild bleeding or infection is rare
- ●No significant radiation or chemical risk from genetic sample collection
Interfering Factors
- ●Recent allogeneic blood transfusion can cause mixed DNA results and affect variant detection
- ●Inadequate DNA quantity or quality may fail to meet sequencing quality metrics
- ●Sample contamination can cause false variant calls
- ●Clinical symptoms may be due to variants in other genes not covered by this test
Compare With Similar Tests
| Test | SLC2A1 Gene Paroxysmal exercise-induced dyskinesia with epilepsy and/or hemolytic anemia NGS Genetic Test | |||
|---|---|---|---|---|
| Comparison | SLC2A1 Gene Paroxysmal exercise-induced dyskinesia with epilepsy and/or hemolytic anemia NGS Genetic Test |
Frequently Asked Questions
What is the SLC2A1 gene?
What is paroxysmal exercise-induced dyskinesia (PED)?
Why is this NGS genetic test recommended?
What type of sample is needed?
Is fasting required for this test?
What does a pathogenic variant result mean?
What does a variant of uncertain significance (VUS) mean?
Can NGS detect all SLC2A1 mutations?
How long will the report take?
Will this test help my family members?
Does DNA Labs India share raw data with the report?
How much does the test cost?
Related Tests
Huntington Disease Mutation Detection Test
₹8,000Myotonic Dystrophy Type 1 Test
₹8,500Nx Gen Sequencing: Duchenne & Becker Muscular Dystrophy Test
₹23,400Nx Gen Sequencing: Tuberous Sclerosis Complex Test
₹27,495MED25 Gene CMT2B2 NGS Genetic Test
₹20,000FLNA Gene Intestinal pseudoobstraction, neuronal NGS Genetic Test
₹20,000Reference Laboratory Services
We serve as a reference laboratory for hospitals and clinics across India. Send samples from your facility with same-day pickup, priority processing, and results delivered through our online portal. Competitive institutional pricing available.
Your Data Privacy
Your medical data is protected under Indian law.
✓ Stored in India: All patient records are stored on servers located in India. No data is transferred outside the country.
✓ DPDP Act Compliant: Under the Digital Personal Data Protection Act 2023, you can request deletion of your records at any time by contacting support.
Book Your Test
Enter your details and we'll connect you within 15 minutes.
